Apatorsen: Phase II ongoing

By WIR Staff | Dec 21, 2015 | 8:00 AM GMT

OncoGenex said an independent DSMB recommended continuation of the investigator-led, open-label, U.S. Phase II Borealis-2

Read the full 158 word article

How to gain access

Continue reading with a
two-week free trial.